Noble Capital raised the firm's price target on CoreCivic to $35 from $28 and keeps an Outperform rating on the shares. Monday's announcement reinforces the value of CoreCivic's assets, with new ICE contracts for additional beds and facility reactivations expected to drive meaningful earnings growth, while a slower-than-expected detainee ramp still leaves substantial opportunity for further capacity expansion and services, the analyst tells investors in a research note.
